Hypersensitivity reactions to biologics in chronic rheumatic diseases: prevalence and associated factors
Considering the predictive factors of hypersensitivity reactions to biologics in clinical practice could help anticipate risks and improve patient safety.
Authors
- O. Saidane (ORCID: https://orcid.org/0000-0002-7521-8018)
- L. Rouached (ORCID: https://orcid.org/0000-0002-4623-6284)
- L. Abdelmoula (ORCID: https://orcid.org/0000-0003-2000-4415)
- Siwar Ben Dhia (ORCID: https://orcid.org/0000-0003-4852-3479)
- R. Tekaya (ORCID: https://orcid.org/0000-0001-9294-9771)
- S. Bouden (ORCID: https://orcid.org/0000-0003-3820-0393)
- A. Ben Tekaya (ORCID: https://orcid.org/0000-0003-3385-2165)
- Ines Mahmoud (ORCID: https://orcid.org/0000-0001-6596-7050)
- Amel Hajjem
Institutions
- Hôpital Charles-Nicolle (TN)
- Tunis El Manar University (TN)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2025-09-26
- DOI
- https://doi.org/10.1080/14740338.2025.2567588
- Primary Topic
- Biosimilars and Bioanalytical Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.00